Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v3-EN | Version v2-FR | |
---|---|---|
Language | English | French |
Date Updated | 2020-11-24 | 2020-10-16 |
Drug Identification Number | 00884502 | 00884502 |
Brand name | LUPRON DEPOT | LUPRON DEPOT |
Common or Proper name | Lupron depot 3.75mg | Lupron depot 3.75mg |
Company Name | ABBVIE CORPORATION | ABBVIE CORPORATION |
Ingredients | LEUPROLIDE ACETATE | LEUPROLIDE ACETATE |
Strength(s) | 3.75MG | 3.75MG |
Dosage form(s) | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | POWDER FOR SUSPENSION, SUSTAINED-RELEASE |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1 syringe (3.75mg) | 1 syringe (3.75mg) |
ATC code | L02AE | L02AE |
ATC description | HORMONES AND RELATED AGENTS | HORMONES AND RELATED AGENTS |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | ||
Actual start date | 2020-10-14 | 2020-10-14 |
Estimated end date | 2021-01-29 | Unknown |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | We have been working with the manufacturing facility to increase production of LUPRON DEPOT and we will continue to distribute supplies as they become available. As production of LUPRON DEPOT continues to increase, we expect inventory in all formulations to stabilize shortly. AbbVie wishes to assure you that we are your primary source of accurate and timely information related to our inventory shortage. The shortage is temporary, and the safety or efficacy of LUPRON DEPOT was not compromised nor affected by the delay. | Please rest assured that we still have inventory of LUPRON Depot 3.75mg (1-month SR). However, due to a recent surge in demand, orders of LUPRON Depot 3.75mg (1-month SR) may take longer to fulfill. We are working closely with wholesalers to fulfill orders in a judicious manner to ensure a constant supply of medication to support patients during this period. Important note: Only LUPRON Depot 3.75 mg (1-Month SR) and LUPRON Depot 11.25 mg (3-Month SR) formulations have gynecologic indications. Other formulations of LUPRON Depot are not indicated in gynecology. |
Health Canada comments |